Tretten
| Product Specs | Description |
|---|---|
| Manufacturer Name | Novo Nordisk |
| Indications | For routine prophylaxis of bleeding in patients with congenital factor XIII Asubunit deficiency |
| Contraindications | Not for use in patients with congenital factor XIII B-subunit Deficiency. Hypersensitivity to the active substance or to any of the excipients. |
| Viral Safety Process | Chromatography steps, including hydrophobic interaction and ion exchange chromatograph. |
| Product Half-Life | Adults 5.1 (2.6) days Children 7.1 (1.9) days |
| Manufacturing Method | Manufactured as an intracellular, soluble protein in yeast. No human or animal derived products are used in the manufacturing process. |
| Storage Requirements/Shelf Life |
|
| Nominal Vial Size & Diluent Volume | 2000 – 3125 IU/3.2 mL |